Zobrazeno 1 - 10
of 22
pro vyhledávání: '"E. Catsafados"'
Autor:
L Iskra, L. Gallo, A Gadducci, S. Mammoliti, P. G. Giannessi, Nicola Ragni, Milena Bruzzone, R. Ridolfi, Isa Brunetti, R. Rosso, Andrea Martoni, Pierfranco Conte, G. Foglia, V. De Lisi, Flavio Carnino, F. Pannuti, Alessandra Rubagotti, R. Maltoni, Francesco Boccardo, E Catsafados
Publikováno v:
Gynecologic Oncology. 65:499-505
From June 1990 to October 1994, 111 advanced ovarian cancer patients with minimal (less than 2 cm) residual disease after platinum-based front-line chemotherapy and second-look laparotomy entered a cooperative randomized study aimed at evaluating the
Autor:
G. Foglia, Gisella Pastorino, E Catsafados, Fulvio Brema, Francesco Boccardo, Domenico Guarneri, Nicola Ragni, Domenico Amoroso, L. Moraglio, F. Pedulla, C Granetto, S. Mammoliti, M.C. Martini, G.F. Addamo, Milena Bruzzone, Loredana Miglietta
Publikováno v:
Oncology. 54:102-107
Background: While ovarian cancer is one of the most sensitive cancers to cytotoxic drugs, with objective response rates of 60-80% routinely being reported in previously untreated pa
Relationships between 99mTc-HMPAO CERASPECT and quantitative EEG observations in Alzheimer’s disease
Autor:
Flavio Nobili, G. Rodriguez, L. Bazzano, Giuliano Mariani, E. Catsafados, Paolo Vitali, G. Taddei
Summary Nineteen patients affected with probable Alzheimer's disease (AD) underwent quantitative electroencephalography (qEEG) and semiquantitative regional cerebral blood flow (rCBF) measurement by Tc-HMPAO (hexamethyl-propylene amine-oxine) SPECT b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b693f608bf3fb8996cfe886582a7ec2a
http://hdl.handle.net/11567/190991
http://hdl.handle.net/11567/190991
Autor:
L, Miglietta, D, Amoroso, M, Bruzzone, C, Granetto, E, Catsafados, S, Mammoliti, D, Guarneri, F, Pedulla, G, Foglia, N, Ragni, M C, Martini, F, Brema, G, Addamo, L, Moraglio, G, Pastorino, F, Boccardo
Publikováno v:
Oncology. 54(2)
While ovarian cancer is one of the most sensitive cancers to cytotoxic drugs, with objective response rates of 60-80% routinely being reported in previously untreated patients, the majority of individuals with advanced disease ultimately relapse. Pac
Autor:
M, Bruzzone, A, Rubagotti, A, Gadducci, E, Catsafados, G, Foglia, I, Brunetti, P G, Giannessi, F, Carnino, L, Iskra, R, Rosso, A, Martoni, F, Pannuti, V, De Lisi, R, Maltoni, R, Ridolfi, S, Mammoliti, L, Gallo, F, Boccardo, N, Ragni, P F, Conte
From June 1990 to October 1994, 111 advanced ovarian cancer patients with minimal (less than 2 cm) residual disease after platinum-based front-line chemotherapy and second-look laparotomy entered a cooperative randomized study aimed at evaluating the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cf09c35b6d90a1cd8103eeece2ef5597
https://hdl.handle.net/11380/739324
https://hdl.handle.net/11380/739324
Autor:
M.C. Locatelli, G. Foglia, F. Turno, Nicola Ragni, Milena Bruzzone, Loredana Miglietta, P. G. Giannessi, G. Luporini, F. Nicosia, Francesco Boccardo, F. Pedulla, A. Gentile, A. D’Antona, E Catsafados, Domenico Amoroso, S. Mammoliti
Encouraging results with Paclitaxel are reported in ovarian cancer patients relapsing and progressing after platinum-based chemotherapy; however, the two populations have different probabilities of a response to a second-line treatment. Here we repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b855dd85d16a6f21aa41f712d0d4ce2
http://hdl.handle.net/11567/247891
http://hdl.handle.net/11567/247891
Autor:
G. Parodi, A. Bellini, L Iskra, Milena Bruzzone, R Algeri, Luigi M. Gallo, A Gadducci, S. Mammoliti, R. Rosso, Flavio Carnino, Nicola Ragni, Alessandra Rubagotti, G. Foglia, Silvana Chiara, S. Rugiati, E Catsafados, Isa Brunetti, Pierfranco Conte, Francesco Boccardo
Publikováno v:
Scopus-Elsevier
PURPOSE The aim of the study was to compare high-versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin as primary chemotherapy for suboptimal stage III and IV ovarian cancer. PATIENTS AND METHODS One hundred forty-five pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0cd474aedd201256b3d481e7252ae6e
http://hdl.handle.net/11577/2554325
http://hdl.handle.net/11577/2554325
Autor:
R, Torrisi, F, Pensa, M A, Orengo, E, Catsafados, P, Ponzani, F, Boccardo, A, Costa, A, Decensi
Publikováno v:
Cancer research. 53(20)
We studied the effect of fenretinide [N-(4-hydroxyphenyl)retinamide (4-HPR)], a synthetic analogue of retinoic acid, on plasma insulin-like growth factor I (IGF-I) levels in a consecutive cohort of stage I breast cancer patients belonging to a random
Autor:
Nicola Ragni, Loredana Miglietta, Francesco Boccardo, E Catsafados, Cristina Granetto, G. Foglia, Domenico Guarneri, Domenico Amoroso, Marco Bruzzone, S. Mammoliti, F. Pedulla
Publikováno v:
European Journal of Cancer. 31:S109
Paclitaxel activity with or without ifosfamide was investigated as salvage therapy in patients (pts) with a.o.c. Group I (n = 20 evaluable) pts received taxol alone 175 mg/m 2 , over 3 hours, every 3 weeks. Group II (n = 13 evaluable pts) received ta
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.